Continuous use of oral contraceptives: an overview of effects and side-effects
This review of oral contraceptive use found that continuous administration decreases menstrual bleeding days and may reduce endometriosis recurrence, though irregular bleeding and long-term data are noted.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (63)
- Add-back therapy in the treatment of endometriosis-associated pain via openalex
- Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis via openalex
- Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy via openalex
- Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use via openalex
- Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters via openalex
- Evidence-based management of endometrioma via openalex
- Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial via openalex
- Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial via openalex
- Maintenance therapy involving a tapering dose of danazol or mid/low doses of oral contraceptive after gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain via openalex
- Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo via openalex
- Repetitive surgery for recurrent symptomatic endometriosis: what to do? via openalex
- W1989556987 via openalex
- doi:10.1055/s-0030-1248263 via openalex
- W1995690188 via openalex
- W1999011481 via openalex
- W2000639680 via openalex
- W2004749740 via openalex
- W2007844596 via openalex
- W2007927070 via openalex
- W2009463280 via openalex
- W2010457699 via openalex
- W2019508903 via openalex
- W2021553800 via openalex
- W2024609097 via openalex
- W2030652710 via openalex
- W2031423046 via openalex
- W2035296610 via openalex
- W2036777235 via openalex
- W2046689771 via openalex
- W2059444229 via openalex
- W2063865593 via openalex
- W2069392551 via openalex
- W2110231896 via openalex
- W2113520440 via openalex
- W2114720923 via openalex
- W2116709305 via openalex
- W2118899690 via openalex
- W2126154655 via openalex
- W2126908963 via openalex
- W2128914859 via openalex
- W2134778793 via openalex
- W2146576387 via openalex
- W2148368274 via openalex
- W2151428696 via openalex
- W2156903058 via openalex
- W2325527069 via openalex
- W2444613356 via openalex
- W2472420732 via openalex
- W4211053272 via openalex
- W4239974122 via openalex
- W4252409292 via openalex
- W142872423 via openalex
- W6683942218 via openalex
- W1967650375 via openalex
- W1967681820 via openalex
- W1969454386 via openalex
- W1970350174 via openalex
- W1974816265 via openalex
- W1977049036 via openalex
- W1977359187 via openalex
- W1978324207 via openalex
- W1984096098 via openalex
- W1987891589 via openalex
Cited by (19)
- Clinical Guidance Paper VVOG: Pharmacological treatment of endometriosis-related pain 2025
- Patient satisfaction with two different management modalities for erratic bleeding during continuous hormone therapy for endometriosis-associated symptoms: A before-after study 2025
- Hormonal Therapy for Inguinal Endometriosis 2023
- Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions 2023
- Current treatments for endometriosis in South Korea: an analysis of nationwide data from 2010 to 2019 2023
- Is endometriosis due to evolutionary maladaptation? 2023
- Non-surgical methods of pain treatment improving the quality of life of patients with endometriosis 2022
- Pathophysiology, diagnosis, and management of endometriosis 2022
- Germany Endometriosis Pattern Changes; Prevalence and Therapy over 2010 and 2019 Years: A Retrospective Cross-Sectional Study 2022
- Continuous oral contraceptives versus long-term pituitary desensitization prior to IVF/ICSI in moderate to severe endometriosis: study protocol of a non-inferiority randomized controlled trial 2019
- Continuous oral contraceptives versus long-term pituitary desensitization prior to IVF/ICSI in moderate to severe endometriosis: study protocol of a non-inferiority randomized controlled trial 2019
- Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive 2016
- Estrogen-progestins and progestins for the management of endometriosis 2016
- Treatment of pain associated with deep endometriosis: alternatives and evidence 2015
- Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted? 2015
- MR-guided focused ultrasound for the treatment of adenomyosis: current insights 2015
- Effective ablation therapy of adenomyosis with ultrasound-guided high-intensity focused ultrasound 2013
- From endometriosis to perineal trauma 2013
- Postoperative medical therapy after surgical treatment of endometriosis: from adjuvant therapy to tertiary prevention 2013
Source provenance
- europepmc
- last seen: 2026-10-10T06:11:15.153948+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:10:53.858194+00:00